| pubmed-article:17289744 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17289744 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17289744 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
| pubmed-article:17289744 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:17289744 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:17289744 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17289744 | pubmed:dateCreated | 2007-3-16 | lld:pubmed |
| pubmed-article:17289744 | pubmed:abstractText | To test the hypothesis that stroke and systemic embolic events (SEE) in the Stroke Prevention using an ORal Thrombin Inhibitor in atrial Fibrillation (SPORTIF) III and V trials were related to blood pressure, and that differences in event rates (stroke and SEE, bleeding) could also be related to the degree of hypertension. | lld:pubmed |
| pubmed-article:17289744 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17289744 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17289744 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17289744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17289744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17289744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17289744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17289744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17289744 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17289744 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:17289744 | pubmed:issn | 0195-668X | lld:pubmed |
| pubmed-article:17289744 | pubmed:author | pubmed-author:LipGregory... | lld:pubmed |
| pubmed-article:17289744 | pubmed:author | pubmed-author:FrisonLarsL | lld:pubmed |
| pubmed-article:17289744 | pubmed:author | pubmed-author:GrindMargaret... | lld:pubmed |
| pubmed-article:17289744 | pubmed:author | pubmed-author:SPORTIF... | lld:pubmed |
| pubmed-article:17289744 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17289744 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:17289744 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17289744 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17289744 | pubmed:pagination | 752-9 | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:meshHeading | pubmed-meshheading:17289744... | lld:pubmed |
| pubmed-article:17289744 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17289744 | pubmed:articleTitle | Effect of hypertension on anticoagulated patients with atrial fibrillation. | lld:pubmed |
| pubmed-article:17289744 | pubmed:affiliation | Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK. g.y.h.lip@bham.ac.uk | lld:pubmed |
| pubmed-article:17289744 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17289744 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17289744 | pubmed:publicationType | Multicenter Study | lld:pubmed |
